Cargando…

A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma

BACKGROUND: Only few studies have been evaluated the clinical characteristics and prognosis of hepatocellular carcinoma (HCC) in young patients. The purpose of this study is to identify prognostic factors and develop an efficient and practical nomogram to predict cancer-specific survival (CSS) in yo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xingchen, Bi, Xinyu, Zhao, Jianjun, Li, Zhiyu, Zhou, Jianguo, Huang, Zhen, Zhang, Yefan, Zhao, Hong, Cai, Jianqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798826/
https://www.ncbi.nlm.nih.gov/pubmed/35116501
http://dx.doi.org/10.21037/tcr-20-3411
_version_ 1784641908940734464
author Li, Xingchen
Bi, Xinyu
Zhao, Jianjun
Li, Zhiyu
Zhou, Jianguo
Huang, Zhen
Zhang, Yefan
Zhao, Hong
Cai, Jianqiang
author_facet Li, Xingchen
Bi, Xinyu
Zhao, Jianjun
Li, Zhiyu
Zhou, Jianguo
Huang, Zhen
Zhang, Yefan
Zhao, Hong
Cai, Jianqiang
author_sort Li, Xingchen
collection PubMed
description BACKGROUND: Only few studies have been evaluated the clinical characteristics and prognosis of hepatocellular carcinoma (HCC) in young patients. The purpose of this study is to identify prognostic factors and develop an efficient and practical nomogram to predict cancer-specific survival (CSS) in young patients with HCC. METHODS: Four hundred and forty-one young patients with HCC who had undergone surgery from 2004–2015 were selected from the Surveillance, Epidemiology, and End Results (SEER) database. The competing risk model, Lasso and Cox regression were used to screen prognostic factors for CSS, and a prognostic nomogram was established using these factors. Thirty-nine young patients with HCC from the National Cancer Center, Cancer Hospital, Chinese Academy of Medical Science were used to validate our model. To further evaluate the predictive performance of our model, the concordance index was calculated and the calibration curves were drawn. The clinical usefulness was evaluated by decision curve analysis (DCA). Finally, all patients were grouped by our nomogram. The survival of different risk groups was analyzed using the Kaplan-Meier method, and the differences among survival curves were compared by the log-rank test. RESULTS: The median survival times of the SEER training group and the external National Cancer Center validation group were 41 and 52 months, respectively. Histological grade, tumor size, Alpha-fetoprotein (AFP), T stage, and M stage were selected as independent factors for CSS, and a prognostic nomogram was established. The concordance indices of the training and external validation groups were 0.76 (95% CI, 0.72 to 0.80) and 0.92 (SE=0.085), respectively. The calibration plots showed good agreement. DCA revealed that our nomogram resulted in a better clinical net benefit than the AJCC 7th edition and Barcelona Clinic Liver Cancer staging systems. Patients were divided into two risk groups according to the cut-off value of 125 of the total points from our nomogram. Kaplan-Meier plots for CSS were performed using the log-rank test, the P-value of which was <0.001. CONCLUSIONS: The practical nomogram resulted in a more-accurate prognostic prediction for young HCC patients after curative liver resection.
format Online
Article
Text
id pubmed-8798826
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87988262022-02-02 A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma Li, Xingchen Bi, Xinyu Zhao, Jianjun Li, Zhiyu Zhou, Jianguo Huang, Zhen Zhang, Yefan Zhao, Hong Cai, Jianqiang Transl Cancer Res Original Article BACKGROUND: Only few studies have been evaluated the clinical characteristics and prognosis of hepatocellular carcinoma (HCC) in young patients. The purpose of this study is to identify prognostic factors and develop an efficient and practical nomogram to predict cancer-specific survival (CSS) in young patients with HCC. METHODS: Four hundred and forty-one young patients with HCC who had undergone surgery from 2004–2015 were selected from the Surveillance, Epidemiology, and End Results (SEER) database. The competing risk model, Lasso and Cox regression were used to screen prognostic factors for CSS, and a prognostic nomogram was established using these factors. Thirty-nine young patients with HCC from the National Cancer Center, Cancer Hospital, Chinese Academy of Medical Science were used to validate our model. To further evaluate the predictive performance of our model, the concordance index was calculated and the calibration curves were drawn. The clinical usefulness was evaluated by decision curve analysis (DCA). Finally, all patients were grouped by our nomogram. The survival of different risk groups was analyzed using the Kaplan-Meier method, and the differences among survival curves were compared by the log-rank test. RESULTS: The median survival times of the SEER training group and the external National Cancer Center validation group were 41 and 52 months, respectively. Histological grade, tumor size, Alpha-fetoprotein (AFP), T stage, and M stage were selected as independent factors for CSS, and a prognostic nomogram was established. The concordance indices of the training and external validation groups were 0.76 (95% CI, 0.72 to 0.80) and 0.92 (SE=0.085), respectively. The calibration plots showed good agreement. DCA revealed that our nomogram resulted in a better clinical net benefit than the AJCC 7th edition and Barcelona Clinic Liver Cancer staging systems. Patients were divided into two risk groups according to the cut-off value of 125 of the total points from our nomogram. Kaplan-Meier plots for CSS were performed using the log-rank test, the P-value of which was <0.001. CONCLUSIONS: The practical nomogram resulted in a more-accurate prognostic prediction for young HCC patients after curative liver resection. AME Publishing Company 2021-04 /pmc/articles/PMC8798826/ /pubmed/35116501 http://dx.doi.org/10.21037/tcr-20-3411 Text en 2021 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Original Article
Li, Xingchen
Bi, Xinyu
Zhao, Jianjun
Li, Zhiyu
Zhou, Jianguo
Huang, Zhen
Zhang, Yefan
Zhao, Hong
Cai, Jianqiang
A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma
title A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma
title_full A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma
title_fullStr A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma
title_full_unstemmed A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma
title_short A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma
title_sort nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798826/
https://www.ncbi.nlm.nih.gov/pubmed/35116501
http://dx.doi.org/10.21037/tcr-20-3411
work_keys_str_mv AT lixingchen anomogramtopredictprognosisaftersurgeryforyoungpatientswithhepatocellularcarcinoma
AT bixinyu anomogramtopredictprognosisaftersurgeryforyoungpatientswithhepatocellularcarcinoma
AT zhaojianjun anomogramtopredictprognosisaftersurgeryforyoungpatientswithhepatocellularcarcinoma
AT lizhiyu anomogramtopredictprognosisaftersurgeryforyoungpatientswithhepatocellularcarcinoma
AT zhoujianguo anomogramtopredictprognosisaftersurgeryforyoungpatientswithhepatocellularcarcinoma
AT huangzhen anomogramtopredictprognosisaftersurgeryforyoungpatientswithhepatocellularcarcinoma
AT zhangyefan anomogramtopredictprognosisaftersurgeryforyoungpatientswithhepatocellularcarcinoma
AT zhaohong anomogramtopredictprognosisaftersurgeryforyoungpatientswithhepatocellularcarcinoma
AT caijianqiang anomogramtopredictprognosisaftersurgeryforyoungpatientswithhepatocellularcarcinoma
AT lixingchen nomogramtopredictprognosisaftersurgeryforyoungpatientswithhepatocellularcarcinoma
AT bixinyu nomogramtopredictprognosisaftersurgeryforyoungpatientswithhepatocellularcarcinoma
AT zhaojianjun nomogramtopredictprognosisaftersurgeryforyoungpatientswithhepatocellularcarcinoma
AT lizhiyu nomogramtopredictprognosisaftersurgeryforyoungpatientswithhepatocellularcarcinoma
AT zhoujianguo nomogramtopredictprognosisaftersurgeryforyoungpatientswithhepatocellularcarcinoma
AT huangzhen nomogramtopredictprognosisaftersurgeryforyoungpatientswithhepatocellularcarcinoma
AT zhangyefan nomogramtopredictprognosisaftersurgeryforyoungpatientswithhepatocellularcarcinoma
AT zhaohong nomogramtopredictprognosisaftersurgeryforyoungpatientswithhepatocellularcarcinoma
AT caijianqiang nomogramtopredictprognosisaftersurgeryforyoungpatientswithhepatocellularcarcinoma